Theralase Technologies Inc. (TSXV: TLT)
Health Care · Health Care Equipment & Supplies · CA
CA$0.19
-30.19% today · -15.9% 1Y
Theralase Technologies Inc. (TSXV: TLT) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $39.73M and employs 16 people.
Over the last twelve months the share price has lost 15.9%, trading between 0.15 and 0.41.
Tweenvest scores Theralase Technologies Inc. across four factors: quality 28/100, value 61/100, growth 0/100. Its strongest factor is value.
TLT price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $39.73M
- Revenue (TTM)
- $614.61K
- P/E
- —
- EPS
- -0.01
- Dividend yield
- —
- Beta (5Y)
- 0.59
- 52-week high
- CA$0.41
- 52-week low
- CA$0.15
- Avg volume (3M)
- —
- Shares outstanding
- 295.67M
- Employees
- 16
- Next earnings
- —
About Theralase Technologies Inc.
Theralase Technologies Inc., a clinical stage pharmaceutical company, engages in the research, development, and commercialization of light activated photo dynamic compounds and their associated drug formulations to treat cancers, bacteria, and viruses in Canada, the United States, and internationally. The company operates through Drug Division and Device Division segments. It designs, develops, manufactures, and markets super-pulsed laser technology for the healing of chronic knee pain, as well as for off-label use to heal various nerve, muscle, and joint conditions. In addition, the company develops TLD-1433, which is in Phase II clinical trial for the treatment of Bacillus Calmette Guérin-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma In-Situ. Further, it researches, develops, manufactures, and distributes controller-less cool laser therapy systems comprising TLC-900, TLC-300, and TLC-100 to healthcare practitioners primarily for the healing of pain. The company has a collaboration with the National Microbiology Laboratory, a Public Health Agency of Canada for the research and development of a Canadian-based SARS-CoV-2 vaccine. Theralase Technologies Inc. is based in Toronto, Canada.
- ISIN
- CA88337V1004
- Listed since
- Feb 13, 2008
- Exchange
- TSX Venture Exchange
- Currency
- CAD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Abbott LaboratoriesNYSE: ABT | $201.83B | $116.87 | +0.19% |
| Intuitive Surgical, Inc.NasdaqGS: ISRG | $133.83B | $376.03 | -0.73% |
| Stryker CorporationNYSE: SYK | $126.37B | $329.49 | +0.01% |
| Medtronic plcNYSE: MDT | $119.49B | $93.23 | -0.13% |
| EssilorLuxottica Société anonymeENXTPA: EL | $87.56B | €161.70 | -0.92% |
| Boston Scientific CorporationNYSE: BSX | $73.00B | $49.32 | -2.08% |
| HOYA CorporationTSE: 7741 | $52.38B | ¥24,895.00 | -1.37% |
| Becton, Dickinson and CompanyNYSE: BDX | $52.30B | $191.25 | -0.39% |
Figures last refreshed Aug 18, 2026.